February 6, 2019

The Early Diagnosis of Alzheimer’s Disease: Discovering Complex Clinical and Pathological Features

Virtual 2021 International Conference on Alzheimer’s & Parkinson’s Diseases

Preparing the System for a Timely Diagnosis and Management of Alzheimer’s Disease: What Can We Be Doing?

In the closing section, Miia Kivipelto, MD, PhD, firstly discusses how pressure on healthcare systems can be reduced through the prevention and delay of dementia, citing the results of the FINGER study amongst other non-pharmacological methods for reducing cognitive decline. She then outlines the pharmacological considerations of patient management and, with the input of the panel, discusses how healthcare system readiness for early detection and diagnosis of Alzheimer’s disease can be improved.

Key Learning Objectives for Biogen’s ADPD 2021 Symposium:

  • Understand how mixed pathologies and varying clinical presentations can affect the early diagnosis of Alzheimer’s disease
  • Gain insights into how comprehensive cognitive assessment tools and fluid and imaging biomarkers can be used to achieve an early diagnosis of Alzheimer’s disease in challenging cases with mixed pathologies
  • Assess the current healthcare system readiness for timely diagnosis of Alzheimer’s disease and management of patients

Disclosure: All panelists received honoraria from Biogen for participation in this symposium.

Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.